Connected care demand lifts medical device chip market to $9.8 billion by 2026

Staticker projects the global medical device semiconductors market will reach $9.8 billion in 2026 as hospitals, OEMs, and consumers push more connected monitors, wearables, and remote diagnostics into care. The shift is being driven by digital health adoption in the US and Europe, plus rising demand for low-power, secure chips across imaging, monitoring, and portable devices.

Why it matters: - Healthcare devices are packing in more chips, which raises semiconductor content per device and expands demand for medical-grade components. - Connected care, home monitoring, and wearable diagnostics are driving demand for secure connectivity, biosensing, processing, and battery optimization. - The market is projected to reach $9.8 billion in 2026.

What happened: - Staticker projected the global medical device semiconductors market will reach USD 9.8 billion in 2026. - The forecast covers chips used in connected monitors, portable diagnostics, imaging systems, and battery-powered therapeutic devices. - The trend tracks broader digital health adoption in the US and Europe, where remote care and wearable monitoring are gaining traction.

The details: - Healthcare OEMs are adding chip functions for biosignal sensing, signal conditioning, edge processing, wireless connectivity, memory, battery management, and secure communication. - FDA cybersecurity expectations for connected medical devices are pushing secure chip architectures and validated software-hardware integration. - The market is also supported by hospital digitization, home-based care, and portable equipment adoption. - Patient monitoring, wearables, and remote diagnostics are expected to account for 31% of total demand in 2026. - Diagnostic imaging is forecast to represent 22% of market value. - Therapeutic and infusion devices are expected to contribute 18%. - Portable diagnostic systems are projected at 16%. - Surgical, implantable, and specialty devices make up the remaining 13%. - Wearable ECG patches, glucose monitors, pulse oximeters, smart inhalers, and connected vital-sign monitors are increasing demand for low-power microcontrollers, analog front-end ICs, sensor chips, RF connectivity chips, and power management ICs. - Analog and mixed-signal semiconductors are expected to hold the largest product share at 33% in 2026. - Microcontrollers and embedded processors are expected to hold 20%. - Power management ICs are expected to hold 18%. - Sensors and biosensing ICs are expected to hold 15%. - Memory, logic, ASICs, FPGAs, and AI accelerator chips are expected to hold 8%. - Connectivity and RF chips are expected to hold 6%. - Analog chips support biosignal capture and signal conditioning. - Power management ICs help control battery life and voltage stability in portable systems. - Microcontrollers manage device control logic. - Sensor ICs support pressure, optical, motion, temperature, and biosignal measurement. - Diagnostic imaging remains one of the most semiconductor-intensive applications, with MRI, CT, ultrasound, X-ray, and fluoroscopy systems all requiring chips for image capture, signal conversion, control logic, image reconstruction, power regulation, and display management. - Portable ultrasound is emerging as a growth opportunity because it combines mobility with high electronics content. - AI-enabled semiconductors are expected to account for 12% to 16% of semiconductor content in medical devices by 2030, according to DataVagyanik Business Intelligence. - Diagnostic imaging is projected to account for 35% to 40% of AI-related chip demand by 2030. - Remote monitoring and wearables are projected at 25% to 30% of AI-related chip demand by 2030. - Portable diagnostics may account for 15% to 20%. - Surgical and therapeutic systems are projected at 10% to 12%. - The competitive landscape includes Texas Instruments, Analog Devices, STMicroelectronics, onsemi, NXP Semiconductors, Microchip Technology, Renesas Electronics, Infineon Technologies, ROHM Semiconductor, ams OSRAM, TE Connectivity, Sensirion, Honeywell, Qualcomm, Broadcom, Nordic Semiconductor, and Silicon Labs. - These suppliers compete on low-power performance, medical-grade reliability, long product availability, regulatory support, secure connectivity, and design-in assistance.

Between the lines: - The market is moving from simple component sourcing to system-level design wins, where suppliers that can combine power efficiency, connectivity, and security gain more strategic value. - AI content is still a minority of current semiconductor demand, but the forecast suggests premium imaging and monitoring devices will pull more advanced chips into regulated healthcare. - The strongest demand is coming from devices that must run longer on batteries while transmitting sensitive data securely.

What’s next: - Semiconductor content per medical device is expected to keep rising as healthcare shifts toward connected care, home monitoring, and energy-efficient electronics. - Growth should continue through 2026 and beyond as more devices combine sensing, processing, and secure connectivity on a single platform. - More design activity is likely to concentrate in wearable monitoring, portable diagnostics, and imaging systems.